// App-Quantinova.ai

: Development of Novel Nanobiosensor for Direct Measurement of the Oral Anticoagulant Agent: Dabigatran Etexilate

Researchers

Presenter

  • Maher M Al Johani

Principal Investigators

  • Raja Chinnappana

  • Shimaa Eissaa

  • Tarek Owaidah

  • Dana Cialla-Mayc

  • Jrgen Poppc

  • Mohammed Zourob

Medical Centers

  • Department of Pathology, College of Medicine, Taibah University, Madinah, Saudi Arabia

  • Friedrich-Schiller-University Jena, Jena, Germany

  • Department of Chemistry, Alfaisal University, Riyadh, Saudi Arabia

  • Al-Faisal University, Jeddah, Saudi Arabia

  • Dept of Pathology & Laboratory Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

  • Institute of Physical Chemistry and Abbe Center of Photonics, Friedrich Schiller University, Jena, Germany

  • King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

Locations

  • Saudi Arabia

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

  • Venous thrombosis

  • Stroke

  • Trauma

Biomarkers

  • N/A

Drug/Treatment

  • Pradax

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A